Literature DB >> 23025667

The presence of local mesenchymal progenitor cells in human degenerated intervertebral discs and possibilities to influence these in vitro: a descriptive study in humans.

Helena Brisby1, Nikolaos Papadimitriou, Camilla Brantsing, Peter Bergh, Anders Lindahl, Helena Barreto Henriksson.   

Abstract

Low back pain is common and degenerated discs (DDs) are believed to be a major cause. In non-degenerated intervertebral discs (IVDs) presence of stem/progenitor cells was recently reported in different mammals (rabbit, rat, pig). Understanding processes of disc degeneration and regenerative mechanisms within DDs is important. The aim of the study was to examine the presence of local stem/progenitor cells in human DDs and if these cell populations could respond to paracrine stimulation in vitro. Tissue biopsies from the IVD region (L3-S1) were collected from 15 patients, age 34-69 years, undergoing surgery (spinal fusion) and mesenchymal stem cells (MSCs) (iliac crest) from 2 donors. Non-DD cells were collected from 1 donor (scoliosis) and chordoma tissue was obtained from (positive control, stem cell markers) 2 donors. The IVD biopsies were investigated for gene and protein expression of: OCT3/4, CD105, CD90, STRO-1, and NOTCH1. DD cell cultures (pellet mass) were performed with conditioned media from MSCs and non-degenerated IVD cells. Pellets were investigated after 7, 14, 28 days for the same stem cell markers as above. Gene expression of OCT3/4 and STRO-1 was detected in 13/15 patient samples, CD105 in 14/15 samples, and CD90 and NOTCH1 were detected 15/15 samples. Immunohistochemistry analysis supported findings on the protein level, in cells sparsely distributed in DDs tissues. DDs cell cultures displayed more undifferentiated appearance with increased expression of CD105, CD90, STRO-1, OCT3/4, NOTCH1, and JAGGED1, which was observed when cultured in conditioned cell culture media from MSCs compared to cell cultures cultured with conditioned media from non-DD cells. Expression of OCT3/4 (multipotency marker) and NOTCH1 (regulator of cell fate), MSC-markers, CD105, CD90, and STRO-1, indicate that primitive cell populations are present within DDs. Furthermore, the possibility to influence cells from DDs by paracrine signaling /soluble factors from MSCs and from nondegenerated IVD cells was observed in vitro indicating that repair processes within human DDs may be stimulated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23025667     DOI: 10.1089/scd.2012.0179

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  28 in total

Review 1.  Stem cell therapy for intervertebral disc regeneration: obstacles and solutions.

Authors:  Daisuke Sakai; Gunnar B J Andersson
Journal:  Nat Rev Rheumatol       Date:  2015-02-24       Impact factor: 20.543

2.  Comparison of biological characteristics of nucleus pulposus mesenchymal stem cells derived from non-degenerative and degenerative human nucleus pulposus.

Authors:  Zhiwei Jia; Pushan Yang; Yaohong Wu; Yong Tang; Yachao Zhao; Jianhong Wu; Deli Wang; Qing He; Dike Ruan
Journal:  Exp Ther Med       Date:  2017-04-27       Impact factor: 2.447

Review 3.  Understanding nucleus pulposus cell phenotype: a prerequisite for stem cell based therapies to treat intervertebral disc degeneration.

Authors:  Hyowon Choi; Zariel I Johnson; Makarand V Risbud
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

4.  Distinguishing characteristics of stem cells derived from different anatomical regions of human degenerated intervertebral discs.

Authors:  Hai Wang; Yue Zhou; Tong-Wei Chu; Chang-Qing Li; Jian Wang; Zheng-Feng Zhang; Bo Huang
Journal:  Eur Spine J       Date:  2016-03-16       Impact factor: 3.134

5.  Is Osteogenic Differentiation of Human Nucleus Pulposus Cells a Possibility for Biological Spinal Fusion?

Authors:  Sharon J Brown; Sarah A Turner; Birender S Balain; Neil T Davidson; Sally Roberts
Journal:  Cartilage       Date:  2018-01-23       Impact factor: 4.634

6.  Poly(γ-glutamic acid) and poly(γ-glutamic acid)-based nanocomplexes enhance type II collagen production in intervertebral disc.

Authors:  Joana C Antunes; Catarina Leite Pereira; Graciosa Q Teixeira; Ricardo V Silva; Joana Caldeira; Sibylle Grad; Raquel M Gonçalves; Mário A Barbosa
Journal:  J Mater Sci Mater Med       Date:  2016-11-24       Impact factor: 3.896

Review 7.  Therapeutic mesenchymal stromal stem cells: Isolation, characterization and role in equine regenerative medicine and metabolic disorders.

Authors:  Mohamad Al Naem; Lynda Bourebaba; Katarzyna Kucharczyk; Michael Röcken; Krzysztof Marycz
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

8.  Aging aggravates intervertebral disc degeneration by regulating transcription factors toward chondrogenesis.

Authors:  Matthew J Silva; Nilsson Holguin
Journal:  FASEB J       Date:  2019-12-24       Impact factor: 5.191

Review 9.  Mesenchymal stem cells: potential application in intervertebral disc regeneration.

Authors:  Aiqun Wei; Bojiang Shen; Lisa Williams; Ashish Diwan
Journal:  Transl Pediatr       Date:  2014-04

Review 10.  IVD progenitor cells: a new horizon for understanding disc homeostasis and repair.

Authors:  Feng-Juan Lyu; Kenneth M Cheung; Zhaomin Zheng; Hua Wang; Daisuke Sakai; Victor Y Leung
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.